Pharmaceutical Technology-06-02-2008

i1-522138-1408671560184.jpg

Report from: India

With rising drug deveopment costs and burdensome clinical trials, Indian-based firms are transferring their research departments to other entities in hopes of saving cash, mitigating risk, and ultimately, buying back the rewards.

i1-522135-1408671571825.jpg

Letting the public inside the drug development process may increase their faith in what we do.